AFP
WST icon

Ausdal Financial Partners’s West Pharmaceutical WST Stock Holding History

Ausdal Financial Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Buy
886
+47
+6% +$11.7K 0.01% 897
2025
Q4 		$231K Hold
839
– – 0.01% 842
2025
Q3 		$220K Buy
+839
New +$204K 0.01% 855

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ausdal Financial Partners's WST Position: Q1 2026 in Review

Ausdal Financial Partners increased its West Pharmaceutical (WST) stake by 5.6% in Q1 2026, buying an estimated $11.7K and bringing the position to 886 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #897.

Ausdal Financial Partners first reported a position in WST in Q3 2025 and has held it in 3 quarters since. The position peaked at $231K in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Ausdal Financial Partners held 886 shares of West Pharmaceutical worth $222K as of Q1 2026.
  • Ausdal Financial Partners bought 47 West Pharmaceutical shares in Q1 2026, an estimated $11.7K.
  • West Pharmaceutical made up 0.01% of Ausdal Financial Partners's portfolio in Q1 2026, its #897 holding.
  • Ausdal Financial Partners first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Ausdal Financial Partners's West Pharmaceutical position peaked at $231K in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.